DOCSLIB.ORG

Dermatology DDX Deck, 2Nd Edition 65

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dermatology DDX Deck, 2Nd Edition 65 63. Herpes simplex (cold sores, fever blisters) PREMALIGNANT AND MALIGNANT NON- 64. Varicella (chicken pox) MELANOMA SKIN TUMORS Dermatology DDX Deck, 2nd Edition 65. Herpes zoster (shingles) 126. Basal cell carcinoma 66. Hand, foot, and mouth disease 127. Actinic keratosis TOPICAL THERAPY 128. Squamous cell carcinoma 1. Basic principles of treatment FUNGAL INFECTIONS 129. Bowen disease 2. Topical corticosteroids 67. Candidiasis (moniliasis) 130. Leukoplakia 68. Candidal balanitis 131. Cutaneous T-cell lymphoma ECZEMA 69. Candidiasis (diaper dermatitis) 132. Paget disease of the breast 3. Acute eczematous inflammation 70. Candidiasis of large skin folds (candidal 133. Extramammary Paget disease 4. Rhus dermatitis (poison ivy, poison oak, intertrigo) 134. Cutaneous metastasis poison sumac) 71. Tinea versicolor 5. Subacute eczematous inflammation 72. Tinea of the nails NEVI AND MALIGNANT MELANOMA 6. Chronic eczematous inflammation 73. Angular cheilitis 135. Nevi, melanocytic nevi, moles 7. Lichen simplex chronicus 74. Cutaneous fungal infections (tinea) 136. Atypical mole syndrome (dysplastic nevus 8. Hand eczema 75. Tinea of the foot syndrome) 9. Asteatotic eczema 76. Tinea of the groin 137. Malignant melanoma, lentigo maligna 10. Chapped, fissured feet 77. Tinea of the body 138. Melanoma mimics 11. Allergic contact dermatitis 78. Tinea of the hand 139. Congenital melanocytic nevi 12. Irritant contact dermatitis 79. Tinea incognito 13. Fingertip eczema 80. Tinea of the scalp VASCULAR TUMORS AND MALFORMATIONS 14. Keratolysis exfoliativa 81. Tinea of the beard 140. Hemangiomas of infancy 15. Nummular eczema 141. Vascular malformations 16. Pompholyx EXANTHEMS AND DRUG REACTIONS 142. Cherry angioma 17. Prurigo nodularis 82. Non-specific viral rash 143. Angiokeratoma 18. Stasis dermatitis 83. Erythema infectiosum 144. Venous lake 19. Venous leg ulcers 84. Cutaneous drug eruptions 145. Pyogenic granuloma 20. Atopic dermatitis 146. Kaposi sarcoma 21. Autosomal dominant ichthyosis vulgaris HYPERSENSITIVITY SYNDROMES AND 147. Telangiectasias 22. Keratosis pilaris VASCULITIS 148. Spider angioma (nevus araneus) 23. Pityriasis alba 85. Erythema multiforme 86. Stevens-Johnson syndrome HAIR AND NAIL DISEASES URTICARIA 87. Erythema nodosum 149. Androgenic alopecia (male pattern 24. Acute urticaria 88. Cutaneous small vessel vasculitis baldness) 25. Chronic urticaria (hypersensitivity vasculitis) 150. Androgenic alopecia in women (female 26. Physical urticaria 89. Henoch-Schönlein purpura pattern hair loss) 27. Angioedema 90. Schamberg disease (Schamberg purpura) 151. Alopecia areata 28. Mastocytosis (urticaria pigmentosa) 91. Sweet syndrome 152. Trichotillomania 29. Pruritic urticarial papules and plaques of 153. Fungal nail infections pregnancy INFESTATIONS AND BITES 154. Nail diseases: 92. Scabies a. Psoriasis ACNE, ROSACEA, AND RELATED 93. Head lice (pediculosis) b. Acute and chronic paronychia, Pseudomas, DISORDERS 94. Bee and wasp stings infection, white spots or bands 30. Comedone acne 95. Lyme disease c. Ridging and beading, habit tic deformity, 31. Pustular acne 96. Rocky Mountain spotted fever onycholysis, distal plate splitting 32. Cystic acne 97. Flea bites d. Digital mucous cyst, nevi and melanoma, 33. Perioral dermatitis 98. Cutaneous larva migrans subungual hematoma 34. Rosacea (acne rosacea) 35. Hidradenitis suppurativa VESICULAR AND BULLOUS DISEASES NEONATAL DISEASE 99. Dermatitis herpetiformis 155. Erythema toxicum neonatorum PSORIASIS AND OTHER PAPULOSQUAMOUS 100. Pemphigus vulgaris 156. Miliaria DISEASES 101. Pemphigus foliaceus 157. Cutis marmorata 36. Psoriasis: hands and feet 102. Bullous pemphigoid 37. Psoriasis: lesions CUTANEOUS MANIFESTATIONS OF 38. Psoriasis: nails CONNECTIVE TISSUE DISEASES INTERNAL DISEASE 39. Psoriasis: special forms 103. Chronic cutaneous lupus 158. Acquired cutaneous paraneoplastic 40. Seborrheic dermatitis 104. Acute cutaneous lupus erythematosus syndromes 41. Grover’s disease (transient acantholytic 105. Dermatomyositis 159. Inherited cutaneous paraneoplastic dermatosis) 106. Scleroderma syndromes 42. Pityriasis rosea 107. Morphea 160. Acanthosis nigricans 43. Lichen planus 161. Neurofibromatosis 44. Lichen sclerosus LIGHT-RELATED DISEASES AND DISORDERS 162. Tuberous sclerosis 45. Pityriasis lichenoides et varioliformis acuta OF PIGMENTATION 163. Granuloma annulare (Mucha-Habermann disease) 108. Sun-damaged skin, photoaging 164. Necrobiosis lipoidica 109. Polymorphous light eruption 165. Pyoderma gangrenosum BACTERIAL INFECTIONS 110. Porphyria cutanea tarda 166. Lasers in dermatology 46. Impetigo 111. Vitiligo 167. Leishmaniasis 47. Cellulitis 112. Idiopathic guttate hypomelanosis 168. Leprosy (Hansen’s Diseases) 48. Folliculitis 113. Lentigo, juvenile lentigo, solar lentigo 49. Pseudofolliculitis barbae 114. Melasma (chloasma, mask of pregnancy) 50. Furuncles and carbuncles 51. Pseudomonas folliculitis BENIGN SKIN TUMORS 52. Otitis externa 115. Seborrheic keratosis 116. Skin tags SEXUALLY TRANSMITTED INFECTIONS 117. Dermatofibroma 53. Syphilis 118. Keloids and hypertrophic scars 54. Chancroid 119. Keratoacanthoma 55. Genital warts 120. Nevus sebaceus 56. Genital herpes simplex 121. Chondrodermatitis nodularis helicis 57. Pubic lice 122. Epidermal cyst 58. Molluscum contagiosum 123. Pilar cyst VIRAL INFECTIONS 124. Sebaceous hyperplasia 59. Warts (verruca vulgaris) 125. Syringomas 60. Flat warts 61. Plantar warts 62. Molluscum contagiosum .
Load more

Recommended publications
  • DERMCASE Test Your Knowledge with Multiple-Choice Cases
    DERMCASE Test your knowledge with multiple-choice cases This month—5 cases: Case 1 1. “What’s wrong with my feet?” 2. “Doc...what is this spot?” 3. “My toenail looks funny!” 4. A foot problem 5. “What’s this rash?” “What’s wrong with my feet?” This 60-year-old woman has had a problem with her feet for several years. What can it be? a. Contact dermatitis b. Pustular psoriasis c. Dyshidrotic eczema d. Mycoses fungoides e. Tinea pedis Answer Pustular psoriasis (answer b) frequently involves the palms and soles. While it does The following have also been used with occur in both sexes, it is most common in mid- varying degrees of success: dle-aged women. It is characterized by recur- • oral etretinate, rent sterile pustules on an erythematous base. • tetracycline, As the pustules dry, they form brown spots. • cyclosporin and The cause of pustular psoriasis is unknown • methotrexate. and once it is established, it can last for years. Cigarette smoking has been associated with There is significant morbidity related to chron- this condition and should be discouraged. ic itch, pain and fissuring. Treatment options consists of: • oil soaks, • emollient creams and ointments, • topical steroids and • retinoid gels. Stanley Wine, MD, FRCPC, is a Dermatologist, Toronto, Ontario. The Canadian Journal of CME / June 2006 63 DERMCASE Case 2 “Doc...what is this spot?” A 42-year-old male presents with a well- defined erythematous atrophic patch with a ker- atotic, raised border. What is it? a. Squamous cell carcinoma b. Bowen’s disease c. Porokeratosis of Mibelli d.
    [Show full text]
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Training Available: in 2012, Lorenzo Kunze, M.E
    2013 Derma-Lo - offers the 2013 Thermo-Lo - offers the reduction of: sun/age spot, milia, reduction of: sun/age spot, milia, telangiectasia / epidermal spider telangiectasia / epidermal spider veins, cherry hemangiomas, veins, cherry hemangiomas and Thermolysis (AC) and Electrolysis Thermolysis (AC) hair removal. (DC) hair removal. Also: active acne, acne scarring, sebaceous hyperplasia, and skin tags. Training Available: In 2012, Lorenzo Kunze, M.E. Includes: Hydro-Lo - treatment IN DENVER ONCE A MONTH developed Chromos, Inc. - which of fine lines and wrinkles, TRAINING AVAILABLE AT in Greek, can be interpreted as enlarged pore reduction, boosts YOUR LOCATION ASK ABOUT “color” or “light” – in essence, the penetration of product into COST without light we have no color. the skin and tightens loose skin. “Dedicated to Excellence” Also: select your choice of (1 of Continuing to provide a professional & positive attitude in the medical 2) LED’s – both are non invasive and aesthetic field. hand-held light probes: BLUE for CHROMOS, Inc. the treatment of acne or Lorenzo Kunze, M.E. Chromos strives to be a guiding INFRARED to increase collagen [email protected] “light” that assists medical and and elastin, Rosacea, increased www.DermaLo.com aesthetic professionals in finding healing properties, minor muscle www.Thermo-Lo.com and pursuing proper education and moderate joint pain. 888-499-8991 / 303-994-7236 and accurate knowledge. Lorenzo Kunze, M.E. Lorenzo is a true visionary - 40 years in the medical and aesthetic field Medical Electrologist / medical educator 1st non-medical professional to provide electrolysis treatments in an OR Treated over 20,000 patients - last 16 years 1st in the U.S.
    [Show full text]
  • Tumors and Tumor-Like Lesions of Blood Vessels 16 F.Ramon
    16_DeSchepper_Tumors_and 15.09.2005 13:27 Uhr Seite 263 Chapter Tumors and Tumor-like Lesions of Blood Vessels 16 F.Ramon Contents 42]. There are two major classification schemes for vas- cular tumors. That of Enzinger et al. [12] relies on 16.1 Introduction . 263 pathological criteria and includes clinical and radiolog- 16.2 Definition and Classification . 264 ical features when appropriate. On the other hand, the 16.2.1 Benign Vascular Tumors . 264 classification of Mulliken and Glowacki [42] is based on 16.2.1.1 Classification of Mulliken . 264 endothelial growth characteristics and distinguishes 16.2.1.2 Classification of Enzinger . 264 16.2.1.3 WHO Classification . 265 hemangiomas from vascular malformations. The latter 16.2.2 Vascular Tumors of Borderline classification shows good correlation with the clinical or Intermediate Malignancy . 265 picture and imaging findings. 16.2.3 Malignant Vascular Tumors . 265 Hemangiomas are characterized by a phase of prolif- 16.2.4 Glomus Tumor . 266 eration and a stationary period, followed by involution. 16.2.5 Hemangiopericytoma . 266 Vascular malformations are no real tumors and can be 16.3 Incidence and Clinical Behavior . 266 divided into low- or high-flow lesions [65]. 16.3.1 Benign Vascular Tumors . 266 Cutaneous and subcutaneous lesions are usually 16.3.2 Angiomatous Syndromes . 267 easily diagnosed and present no significant diagnostic 16.3.3 Hemangioendothelioma . 267 problems. On the other hand, hemangiomas or vascular 16.3.4 Angiosarcomas . 268 16.3.5 Glomus Tumor . 268 malformations that arise in deep soft tissue must be dif- 16.3.6 Hemangiopericytoma .
    [Show full text]
  • Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting As
    Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting as Chronic Ulcers with Vasculitis: A Case Report and Discussion Anny Xiao, DO,* Erin Lowe, DO,** Richard Miller, DO, FAOCD*** *Traditional Rotating Intern, PGY-1, Largo Medical Center, Largo, FL **Dermatology Resident, PGY-2, Largo Medical Center, Largo, FL ***Program Director, Dermatology Residency, Largo Medical Center, Largo, FL Disclosures: None Correspondence: Anny Xiao, DO; Largo Medical Center, Graduate Medical Education, 201 14th St. SW, Largo, FL 33770; 510-684-4190; [email protected] Abstract Leprosy is a rare, chronic, granulomatous infectious disease with cutaneous and neurologic sequelae. It can be a challenging differential diagnosis in dermatology practice due to several overlapping features with rheumatologic disorders. Patients with leprosy can develop reactive states as a result of immune complex-mediated inflammatory processes, leading to the appearance of additional cutaneous lesions that may further complicate the clinical picture. We describe a case of a woman presenting with a long history of a recurrent bullous rash with chronic ulcers, with an evolution of vasculitic diagnoses, who was later determined to have lepromatous leprosy with reactive erythema nodosum leprosum (ENL). Introduction accompanied by an intense bullous purpuric rash on management of sepsis secondary to bacteremia, Leprosy is a slowly progressive disease caused by bilateral arms and face. For these complaints she was with lower-extremity cellulitis as the suspected infection with Mycobacterium leprae (M. leprae). seen in a Complex Medical Dermatology Clinic and source. A skin biopsy was taken from the left thigh, Spread continues at a steady rate in several endemic clinically diagnosed with cutaneous polyarteritis and histopathology showed epidermal ulceration countries, with more than 200,000 new cases nodosa.
    [Show full text]
  • Rosacea: an Update
    REVIEW JONELLE K. MCDONNELL, MD KENNETH J. TOMECKI, MD Department of Dermatology, Cleveland Clinic Department of Dermatology, Cleveland Clinic Rosacea: An update • ABSTRACT | >1 OSACEA is a chronic and recurrent LAM inflammatory skin disease characterized Rosacea is a common inflammatory skin disease affecting by erythema, papules, pustules, telangiectasia, the central face of adults. Its etiology is unknown. Early and occasionally sebaceous hyperplasia, which diagnosis and appropriate treatment, usually with topical or primarily affects the central face. The disease systemic antibiotics or both, minimizes symptoms and helps evolves in stages and affects middle-aged to prevent complications. adults. Early diagnosis and thoughtful manage- ment help to control the disease and to mini- • KEY POINTS mize the patient's discomfort and emotional distress. Historically, rosacea has been a mis- Rosacea has a spectrum of cutaneous clinical findings: understood disorder, often attributed to alco- facial erythema, papules, pustules, telangiectasia, and holism and acne.1 rhinophyma. • INCIDENCE Common triggers are sunlight, stress, exposure to extreme Rosacea is a common and chronic disease that heat or cold, alcohol, hot beverages, and spicy foods. affects approximately 13 million Americans, or about 1 in 20 people. Because rosacea fre- Rosacea can resemble other diseases, including acne, quently affects people of northern European seborrheic dermatitis, systemic lupus erythematosus, and heritage, it is often called the "curse of the sarcoidosis. Celts."2 In contrast, it is rarely seen in dark- skinned individuals.3 In most patients, the Ocular involvement occurs in more than 50% of patients onset occurs between the ages of 30 and 50. with rosacea. The early stages affect women more often than men at a ratio of 3 to 1, but men more often Oral tetracycline and topical metronidazole are the develop disfiguring rhinophyma.
    [Show full text]
  • Erythema Nodosum (En)
    Buffalo Medical Group, P.C. Robert E. Kalb, M.D. Phone: (716) 630-1102 Fax: (716) 633-6507 Department of Dermatology 325 Essjay Road Williamsville, New York 14221 ERYTHEMA NODOSUM (EN) Erythema Nodosum (EN) is a relatively uncommon reaction in the skin consisting of red shiny tender nodular lesions most commonly found on the legs. The erythema refers to the red color that is seen at the surface of the skin. The nodosum refers to the fact that these lesions feel like bumps or nodules underneath the skin surface. Erythema nodosum is a reaction pattern occurring in the subcutaneous tissue and fat. It may be preceded by a low grade fever, fatigue, and joint pains. In about half of the cases, there is an internal condition occurring in the body which contributes to its formation. These include the use of certain medications, certain infections, and a number of other less likely causes. In order to identify cause for the erythema nodosum, it may be necessary to perform blood and laboratory tests. At times, however, the cause cannot be determined and erythema nodosum is considered to be idiopathic in nature. Erythema nodosum often runs an acute course lasting for a brief period from weeks to months. In a small percentage of cases, it can be a more chronic condition. The red nodules are usually confined to the lower legs, but can develop anywhere there is fat under the skin including the thighs, arms, and trunk. Initially, the lesions are more red and inflamed in appearance, but with time become more bruise like.
    [Show full text]
  • Diagnostic Pitfall of Localized Lentigo Accompanied by Post-Inflammatory
    Letter to the Editor Diagnostic pitfall of localized lentigo accompanied by post-inflammatory pigmentation on the palm with a several-month history Keisuke Imafuku, Hiroo Hata, Shinya Kitamura, Toshifumi Nomura, Hiroshi Shimizu Department of Dermatology, Hokkaido University Graduate School of MedicineNorth 15, West 7, Kita-ku, Sapporo 060- 8638, Japan Corresponding author: Dr. Hiroo Hata, MD, PhD, E-mail: [email protected] Sir, When dermatologists see acquired and well- circumscribed pigmented macules on the palm, dorsal hand or forearm of the elderly, they tend to consider blue nevus, hematoma, nevus cell nevus and malignant melanoma as differential diagnoses [1]. We a b herein described the very rare case of localized lentigo Figure 1: Clinical manifestations. a. The macule is brown to dark black, accompanied by post-inflammatory pigmentation well-demarcated, flat, round and 3 x 4 mm in size. b. Dermoscopy of the macule shows homogenous brownish pigmentation without the in a patient who has been treated for palmoplanter parallel ridge or furrow pattern that is commonly observed in acral pustulosis for a long time. This eruption mimicked lentiginous lesion some kinds of lentiginous lesion and it was difficult to diagnose clinically. A 59-year-old female was referred to our hospital with a pigmented macule on her left palm. She had been to the family doctor for treatment of palmoplanter pustulosis by topical steroid ointment application for several years. According to the a history-taking interview, she said that the lesion had b appeared 5 months before referral to our hospital as a tiny pigmented macule and had gradually enlarged during those 5 months (Fig.
    [Show full text]
  • Pattern of Pediatric Dermatoses in a Tertiary Care Centre in Karnataka
    Original Research Article Pattern of Pediatric Dermatoses in a Tertiary Care Centre in Karnataka Bangaru H1,*, Nanjundaswamy BL2 1Assistant Professor, 2Professor, Mysore Medical College & Research Institute, Mysore *Corresponding Author: Email: [email protected] Abstract Background: Skin diseases are major health problem in the pediatric age group and it reflects the status of health, nutrition, hygiene and personal cleanliness of a community. Objective: 1. To estimate the proportion of pediatric skin diseases. 2. To estimate and test the impact of age and sex on pediatric skin diseases 3. To prioritize the condition of skin diseases among pediatric age group. Inclusion criteria: All cases registered in outpatient records aged 0-18 years. Exclusion criteria: None. Materials and Methods: Study design: Retrospective study. Retrospective collection of data from the out patient records, of all children aged 0-18 years, who had attended as out-patient, in dermatology out-patient department, in Krishna Rajendra Hospital, Mysore, Karnataka. The diseases will be tabulated based on age, sex and etiology and results will be analysed. Sample size: With the incidence of pediatric dermatoses 9-37%, level of significance 5%, absolute allowable error 5%, using confidence interval approach, the sample size is 131-373. However, over a period of six months, 3753 pediatric case sheets have been considered for the study. Statistical method: Objective 1 is analysed through frequency and proportion, objective 2 is analysed through bivariate frequency technique using frequency, chi-square test and object 3 is addressed through frequency technique. Results: Out of 16500 out patients 3753 were children aged 0-18 years. Males (1984) were slightly more than females (1769) with male to female ratio of 1.12:1.
    [Show full text]
  • 1.7-Micron Optical Coherence Tomography Angiography for Characterization of Skin Lesions- a Feasibility Study
    UC Irvine UC Irvine Previously Published Works Title 1.7-Micron Optical Coherence Tomography Angiography for Characterization of Skin Lesions- A Feasibility Study. Permalink https://escholarship.org/uc/item/33m4x381 Journal IEEE transactions on medical imaging, 40(9) ISSN 0278-0062 Authors Li, Yan Murthy, Raksha Sreeramachandra Zhu, Yirui et al. Publication Date 2021-09-01 DOI 10.1109/tmi.2021.3081066 Peer reviewed eScholarship.org Powered by the California Digital Library University of California This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TMI.2021.3081066, IEEE Transactions on Medical Imaging IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. xx, NO. X, NOVEMBER 2020 1 1.7-micron Optical Coherence Tomography Angiography for Characterization of Skin Lesions – A Feasibility Study Yan Li, Raksha Sreeramachandra Murthy, Yirui Zhu, Fengyi Zhang, Jianing Tang, Joseph N. Mehrabi, Kristen M. Kelly, and Zhongping Chen Abstract—Optical coherence tomography (OCT) is a non- In recent decades, many novel noninvasive biomedical invasive diagnostic method that offers real-time imaging modalities, such as magnetic resonance imaging visualization of the layered architecture of the skin in vivo. (MRI), ultrasonography, reflectance confocal microscopy The 1.7-micron OCT system has been applied in cardiology, (RCM), and optical coherence tomography (OCT) have been gynecology and dermatology, demonstrating an improved penetration depth in contrast to conventional 1.3-micron utilized in both clinical and research settings to aid in the OCT. To further extend the capability, we developed a 1.7- diagnosis of skin cancer, permitting real-time visualization of micron OCT/OCT angiography (OCTA) system that allows internal structures and their functions (e.g.
    [Show full text]
  • MYELOPATHY ASSOCIATED with SYSTEMIC LUPUS ERYTHEMATOSUS (Erythema Nodosum)
    Paraplegia 16 (1978-79) 282-294 Original Articles MYELOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (Erythema Nodosum) L. S. KEWALRAMANI, M.D., M.S.Orth., S. SALEEM, M.D. and D. BERTRAND, M.T. (ASCP) Texas Institute for Rehabilitation and Research and Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, U.S.A. Abstract. Two patients with sudden onset of myelopathy associated with Systemic Lupus Erythematosus (Erythema Nodosum) are described. Pertinent literature is extensively reviewed and these two new patients are added to previously reported 26 patients. Key words: Myelopathy; Meningoencephalomyelopathy; Systemic lupus erythematosus. NEUROLOGICAL manifestations of systemic lupus erythematosus (SLE) have only recently been emphasised although they were mentioned by Kaposi in 1875, who observed stupor and coma as terminal manifestations of the disease. But focal neurological abnormalities were first reported by Osler (1903) and since then there have been several reports in the literature. Most commonly reported entities have been acute organic brain syndrome, seizures and cerebrovascular disorders. Chorea, Guillain Barre syndrome, subarachnoid haemorrhage, peripheral neuro­ pathy and cranial nerve palsies associated with SLE have also been reported on a few occasions. Myelopathy, however, has not received adequate emphasis as a complication of SLE. Fisher and Gilmour reported the first case of flaccid paraplegia in a female with SLE in 1939. Since then only 25 additional cases have been reported in the medical literature over the past 38 years. Twenty cases have been described in sufficient detail and six briefly, to permit a meaningful review of the spinal cord involvement in this disease. We feel that there are probably many more unreported cases of myelopathy associated with SLE.
    [Show full text]
  • COVID-19 Mrna Pfizer- Biontech Vaccine Analysis Print
    COVID-19 mRNA Pfizer- BioNTech Vaccine Analysis Print All UK spontaneous reports received between 9/12/20 and 22/09/21 for mRNA Pfizer/BioNTech vaccine. A report of a suspected ADR to the Yellow Card scheme does not necessarily mean that it was caused by the vaccine, only that the reporter has a suspicion it may have. Underlying or previously undiagnosed illness unrelated to vaccination can also be factors in such reports. The relative number and nature of reports should therefore not be used to compare the safety of the different vaccines. All reports are kept under continual review in order to identify possible new risks. Report Run Date: 24-Sep-2021, Page 1 Case Series Drug Analysis Print Name: COVID-19 mRNA Pfizer- BioNTech vaccine analysis print Report Run Date: 24-Sep-2021 Data Lock Date: 22-Sep-2021 18:30:09 MedDRA Version: MedDRA 24.0 Reaction Name Total Fatal Blood disorders Anaemia deficiencies Anaemia folate deficiency 1 0 Anaemia vitamin B12 deficiency 2 0 Deficiency anaemia 1 0 Iron deficiency anaemia 6 0 Anaemias NEC Anaemia 97 0 Anaemia macrocytic 1 0 Anaemia megaloblastic 1 0 Autoimmune anaemia 2 0 Blood loss anaemia 1 0 Microcytic anaemia 1 0 Anaemias haemolytic NEC Coombs negative haemolytic anaemia 1 0 Haemolytic anaemia 6 0 Anaemias haemolytic immune Autoimmune haemolytic anaemia 9 0 Anaemias haemolytic mechanical factor Microangiopathic haemolytic anaemia 1 0 Bleeding tendencies Haemorrhagic diathesis 1 0 Increased tendency to bruise 35 0 Spontaneous haematoma 2 0 Coagulation factor deficiencies Acquired haemophilia
    [Show full text]